Pegcetacoplan Acetate combines a complement-targeting peptide core with a PEGylated architecture that enhances solubility and hydrodynamic size. The conjugated polyethylene glycol segment reduces aggregation and modulates pharmacokinetic modeling in vitro. Researchers study its binding equilibria to complement proteins and structural organization in solution. Applications include complement-pathway mechanism research, ligand-protein interaction mapping, and bioconjugate optimization.
CAT No: R2537
Pegcetacoplan acetate is a synthetic complement C3 inhibitor designed to modulate the activity of the complement system, a crucial component of innate immunity. As a PEGylated cyclic peptide, Pegcetacoplan acetate exhibits enhanced stability and solubility, enabling researchers to investigate its unique mechanism of selectively binding to C3 and C3b proteins. The compound's structural features allow it to effectively block the cleavage of C3, thereby preventing the downstream activation of the complement cascade. This targeted approach offers significant value for applications in immunological research and disease modeling, where precise modulation of the complement pathway is essential for understanding inflammatory processes and immune-mediated damage. Due to its high specificity and reversible binding characteristics, Pegcetacoplan acetate has become an indispensable tool for scientists exploring the role of complement activation in various pathological contexts.
Complement Pathway Research: In the field of immunology, Pegcetacoplan acetate serves as a valuable probe for dissecting the role of the complement system in host defense and inflammatory responses. By selectively inhibiting C3 activation, the compound enables researchers to study the consequences of complement blockade on immune cell recruitment, opsonization, and phagocytosis. This is particularly important for elucidating the involvement of complement in autoimmune and inflammatory diseases, as well as in the regulation of tissue homeostasis. Utilizing Pegcetacoplan acetate in in vitro assays and animal models facilitates the identification of novel therapeutic targets and the development of complement-modulating strategies for disease intervention.
Hematology and Hemolysis Studies: The ability of Pegcetacoplan acetate to prevent complement-mediated hemolysis makes it an essential reagent for investigating red blood cell destruction in hemolytic disorders. By blocking the formation of the membrane attack complex, the compound allows researchers to model conditions such as paroxysmal nocturnal hemoglobinuria (PNH) and to assess the impact of complement inhibition on erythrocyte survival. This application is fundamental for understanding the mechanisms underlying hemolytic anemia and for evaluating potential interventions aimed at preserving red blood cell integrity.
Transplantation Immunology: In transplantation research, Pegcetacoplan acetate is utilized to explore the effects of complement inhibition on graft survival and rejection. Complement activation is a key contributor to ischemia-reperfusion injury and hyperacute rejection following organ transplantation. By incorporating this C3 inhibitor into experimental protocols, scientists can assess the extent to which complement blockade mitigates inflammatory damage and promotes graft tolerance. Such studies are critical for optimizing immunosuppressive regimens and improving long-term transplant outcomes.
Ophthalmic Disease Modeling: The role of complement in retinal and choroidal diseases has been increasingly recognized, and Pegcetacoplan acetate provides a powerful means to investigate these mechanisms. In models of age-related macular degeneration and other complement-mediated ocular disorders, the compound is used to inhibit C3 activation and evaluate its effects on retinal cell survival, inflammation, and neovascularization. This application supports the development of new research tools and therapeutic approaches for vision-threatening conditions linked to dysregulated complement activity.
Neuroinflammation and Neurodegeneration: Pegcetacoplan acetate is also advancing the study of complement's involvement in neuroinflammatory and neurodegenerative diseases. By blocking C3 cleavage within the central nervous system, the compound enables researchers to dissect the contribution of complement activation to neuronal injury, synaptic loss, and glial cell activation. These investigations are vital for unraveling the complex interplay between the immune system and the brain, particularly in disorders such as Alzheimer's disease, multiple sclerosis, and other conditions characterized by chronic inflammation and neurodegeneration.
In summary, Pegcetacoplan acetate stands as a versatile and highly specialized tool for scientific research across multiple disciplines. Its unique ability to selectively inhibit complement C3 activation underpins a broad range of applications, from immunology and hematology to transplantation, ophthalmology, and neuroscience. By enabling precise control over complement activity, this compound supports the discovery of novel biological insights and the advancement of innovative strategies for the study of immune-mediated diseases and tissue injury.
2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More